Last updated on April 16, 2014 at 1:21 EDT

Latest Adrenomed AG Stories

2013-01-02 12:22:33

HENNIGSDORF, Germany, Jan. 2, 2013 /PRNewswire/ -- The German corporation Adrenomed AG today announced its intentions to contribute to the reduction of mortality from sepsis and septic shock. Sepsis is an advanced systemic infection that travels via the blood stream to many of the body's vital organs, which can lead to death and disability. Adrenomed AG has developed the new first-in-class compound, Adrecizumab. The drug targets the vasoactive hormone adrenomedullin as one of the key...